« Older Entries
Newer Entries »
Merus Secures €31 Million in Series B Round Extension
Thursday, October 3rd, 2013
- Investment brings Series B to a total of €47.6 million
- Johnson & Johnson Development Corporation joins as new investor; receives board seat
Utrecht, The Netherlands, October 3, 2013 – Merus B.V., a biop [...]
ARGEN-X initiates phase Ib study of ARGX-111 in cancer
Tuesday, September 17th, 2013
SIMPLE Antibody™ with unique mode of action addressing c-Met positive tumors Breda, the Netherlands, and Ghent, Belgium, September 17, 2013 – arGEN-X, a clinical stage human monoclonal antibody therapeutics compa [...]
« Older Entries
Newer Entries »